Study finds that transgender women on hormone therapy may have early-stage prostate cancer missed by current PSA screening guidelines.

THURSDAY, June 20, 2024 -- Black patients are more likely to experience adverse cardiovascular outcomes after systemic androgen deprivation therapy...

Transgender women continue to face the risk of developing prostate cancer. A recent study conducted by Cedars-Sinai Cancer researchers, published in...

A research effort led by Dean Tang, PhD, of Roswell Park Comprehensive Cancer Center, USA, sheds light on a critical area of oncologic study — the...

A recent study published in the Journal of the American Medical Association (JAMA) has shed new light on prostate-specific antigen (PSA) values among...

A new study published in JAMA Network Open by an international cohort of researchers provides the latest data on the effectiveness of treating...

The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details best practices for using radiation therapy...

FRIDAY, June 28, 2024 -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published online June 18 in...

New study cautions transgender women and physicians to approach standard screening guidelines with caution. Hormone therapy in transgender women can...